General Information of the Compound
| Compound ID |
CP0405613
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
methyl 3-[(3R)-8-[[2-[(4-chlorophenyl)methoxy]acetyl]amino]-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H31ClN4O7
|
||||||||||||||||||
| Molecular Weight |
595.052
|
||||||||||||||||||
| Canonical SMILES |
COC(=O)CC[C@H]1NC(=O)c2cc(Oc3cccc(c3)N(C)C)c(NC(=O)COCc3ccc(Cl)cc3)cc2NC1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H31ClN4O7/c1-35(2)20-5-4-6-21(13-20)42-26-14-22-24(34-30(39)23(33-29(22)38)11-12-28(37)40-3)15-25(26)32-27(36)17-41-16-18-7-9-19(31)10-8-18/h4-10,13-15,23H,11-12,16-17H2,1-3H3,(H,32,36)(H,33,38)(H,34,39)/t23-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VUZWLQCMNZAQCT-HSZRJFAPSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03645, Nucleotide-binding oligomerization domain-containing protein 1
Protein ID: PT03970, Nucleotide-binding oligomerization domain-containing protein 2